← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sibtech, Inc.
Brookfield, CT
$12,394,557
Total funding
22
Grants
Funding over time
peak $2M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$12,295,465 · 21
DOE$99,092 · 1
By mechanism
R44$6,482,557 · 5
R43$2,663,094 · 12
N43$2,524,942 · 2
R21$325,137 · 1
N01$299,735 · 1
—$99,092 · 1
Investigators at Sibtech, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
IGF::OT::IGF SYSTEMIC RADIONUCLIDE THERAPY TARGETED TO VEGF RECEPTORS IN TUMOR VASCULATURE$1,999,999
N43 · FY2017 · CA
Clinical development of 18F PET tracer for imaging VEGF receptors$1,016,118
R44 · FY2015 · CA
Targeted delivery of Lu-177 to tumor vasculature$985,550
R44 · FY2012 · CA
Targeted delivery of Lu-177 to tumor vasculature$786,124
R44 · FY2011 · CA
TARGETING ANGIOGENESIS WITH TOXIN-VEGF FUSION PROTEINS$613,618
R44 · FY2002 · CA
VEGF-based Targeted Imaging of Tumor Vasculature$564,762
R44 · FY2008 · CA
TARGETING ANGIOGENESIS WITH TOXIN VEGF FUSION PROTEINS$545,700
R44 · FY2001 · CA
VEGF-based Targeted Imaging of Tumor Vasculature$545,177
R44 · FY2007 · CA
Clinical development of 18F PET tracer for imaging VEGF receptors$456,892
R44 · FY2016 · CA
Targeted Delivery of Cardioprotective Drugs$385,462
R43 · FY2010 · HL
NEW METHODOLOGY FOR VEGF-MEDIATED GENE DELIVERY$376,011
R44 · FY2001 · HL
NEW METHODOLOGY FOR VEGF-MEDIATED GENE DELIVERY$369,685
R44 · FY2000 · HL
IGF::OT::IGF SYSTEMIC RADIONUCLIDE THERAPY TARGETED TO VEGF RECEPTORS IN TUMOR VASCULATURE$299,999
N43 · FY2015 · CA
Topic 375: 18F PET Tracer For Imaging PD-L1 (Moonshot)$299,735
N01 · FY2018 · CA
Targeted photoacoustic imaging of VEGF receptors in angiogenic vasculature$286,918
R43 · FY2011 · EB
Targeted delivery of Lu-177 to tumor vasculature$286,382
R43 · FY2009 · CA
Targeting GRP78/BIP As An Adjunct Therapy For EGFR-positive Breast Cancer$245,842
R43 · FY2008 · CA
IGF::OT::IGF TO TARGET SPECIFIC MOLECULAR IMAGING AGENTS IN COMBINATION WITH EXISTING IMAGING MODALITIES TO DETECT HIGH RISK ATHEROSCLEROTIC PLAQUE$224,944
N43 · FY2014 · HL
Targeted drug delivery to tumor microenvironment$224,833
R43 · FY2015 · CA
Clinical development of 18F PET tracer for imaging VEGF receptors$222,920
R44 · FY2014 · CA